Skip to main content
×
Home

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia

  • SOPHIE RÉMILLARD (a1), EMMANUELLE POURCHER (a2) (a3) and HENRI COHEN (a1) (a2) (a3)
Abstract

There is evidence in the literature that cognitive functions in schizophrenia (SC) may be improved by atypical neuroleptics (NLPs) in contrast to typical medication, but there is still controversy regarding this apparent superiority of atypical drugs. In this study, we assessed the differential effects of risperidone and haloperidol on verbal memory, attention, and psychiatric symptoms in SC. The performance of 28 SC participants, randomly assigned to risperidone (2–6 mg/day) or haloperidol (2–40 mg/day), was compared with that of healthy controls. The California Verbal Learning Test (CVLT), the d2 Cancellation Test, and the Positive and Negative Symptoms Scale were administered at baseline and 3, 6, and 12 months. Relative to controls, all SC participants showed markedly impaired verbal memory and processing speed at each assessment period. There was no differential effect between the two NLPs on CVLT and d2 performance. However, risperidone was more effective than haloperidol in reducing psychiatric symptoms. Improvement in symptom severity was not associated with improvement in neurocognitive performance on these specific tests. Neither conventional nor atypical neuroleptic medications improved neurocognitive functioning over a 12-month follow-up, suggesting that psychopathological improvement under risperidone is independent of cognitive function. (JINS, 2008, 14, 110–118.)

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia
      Available formats
      ×
Copyright
Corresponding author
Correspondence and reprint request to: Henri Cohen, Psychology and Cognitive Neuroscience Laboratory, Université Paris Descartes-CNRS, 71 Ave. Edouard-Vaillant, Boulogne-Billancourt 92774, France. E-mail: henri.cohen@univ-paris5.fr
References
Hide All

REFERENCES

Aleman, A., Hijman, R., de Haan, E.H., & Kahn, R.S. (1999). Memory impairment in schizophrenia: A meta-analysis. American Journal of Psychiatry, 156, 13581366.
Bilder, R.M., Goldman, R.S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., Chakos, M., Cooper, T.B., Horowitz, T.L., & Lieberman, J.A. (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 159, 10181028.
Bozikas, V.P., Kosmidis, M.H., Kioperlidou, K., & Karovatos, A. (2004). Relationship between psychopathology and cognitive functioning in schizophrenia. Comprehensive Psychiatry, 45, 392400.
Brickenkamp, R. & Zillmer, E. (1998). The D2 Test of Attention (1st US ed.). Seattle: Hogrefe & Huber Publishers.
Buschke, H. & Fuld, P.A. (1974). Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology, 24, 10191025.
Carman, J., Peuskens, J., & Vangeneugden, A. (1995). Risperidone in the treatment of negative symptoms of schizophrenia: A meta-analysis. International Clinical Psychopharmacology, 10, 207213.
Chouinard, G., Ross-Chouinard, A., Annable, L., & Jones, B.D. (1980). Extrapyramidal Symptom Rating Scale (ESRS). Canadian Journal of Neurological Sciences, 7, 233243.
Cuesta, M.J., Peralta, V., & Zarzuela, A. (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study. Schizophrenia Research, 48, 1728.
Delis, D.C., Kramer, J.H., Kaplan, E., & Ober, B.A. (1987). The California Verbal Learning Test—Research edition. New York: Psychological Corporation.
Epstein, J.I., Keefe, R.S., Roitman, S.L., Harvey, P.D., & Mohs, R.C. (1996). Impact of neuroleptic medications on continuous performance test measures in schizophrenia. Biological Psychiatry, 39, 902905.
Fletcher, P.C., Shallice, T., & Dolan, R.J. (1998). The functional roles of prefrontal cortex in episodic memory. I. Encoding. Brain, 121, 12391248.
Frith, C.D. (1984). Schizophrenia, memory, and anticholinergic drugs. Journal of Abnormal Psychology, 93, 339341.
Fukuzako, H., Kodama, S., Fukuzako, T., Yamada, K., Hokazono, Y., Ueyama, K., Hashiguchi, T., Takenouchi, K., Takigawa, M., & Takeuchi, K. (1995). Shortening of the hippocampal formation in first-episode schizophrenic patients. Psychiatry and Clinical Neurosciences, 49, 157161.
Green, M.F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321330.
Green, M.F., Marder, S.R., Glynn, S.M., McGurk, S.R., Wirshing, W.C., Wirshing, D.A., Liberman, R.P., & Mintz, J. (2002). The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone. Biological Psychiatry, 51, 972978.
Harvey, P.D., Green, M.F., McGurk, S.R., & Meltzer, H.Y. (2003). Changes in cognitive functioning with risperidone and olanzapine treatment: A large-scale, double-blind, randomized study. Psychopharmacology, 169, 404411.
Harvey, P.D., Moriarty, P.J., Serper, M.R., Schnur, E., & Lieber, D. (2000). Practice-related improvement in information processing with novel antipsychotic treatment. Schizophrenia Research, 46, 139148.
Heckers, S., Rauch, S.L., Goff, D., Savage, C.R., Schacter, D.L., Fischman, A.L., & Alpert, N.M. (1998). Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature Neuroscience, 1, 318323.
Hill, S.K., Beers, S.R., Kmiec, J.A., Keshavan, M.S., & Sweeney, J.A. (2004). Impairment of verbal memory and learning in antipsychotic-naive patients with first-episode schizophrenia. Schizophrenia Research, 68, 127136.
Holthausen, E.A., Wiersma, D., Sitskoorn, M.M., Dingemans, P.M., Schene, A.H., & van den Bosch, R.J. (2003). Long-term memory deficits in schizophrenia: Primary or secondary dysfunction? Neuropsychology, 17, 539547.
Hong, K.S., Kim, J.G., Koh, H.J., Koo, M.S., Kim, J.H., Lee, D., & Kim, E. (2002). Effects of risperidone on information processing and attention in first-episode schizophrenia. Schizophrenia Research, 53, 716.
Hughes, C., Kumari, V., Soni, W., Das, M., Binneman, B., Drozd, S., O'Neil, S., Mathew, V., & Sharma, T. (2003). Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research, 59, 137146.
Johnson, S.C., Saykin, A.J., Flashman, L.A., McAllister, T.W., & Sparling, M.B. (2001). Brain activation on fMRI and verbal memory ability: Functional neuroanatomic correlates of CVLT performances. Journal of the International Neuropsychological Society, 7, 5562.
Kay, S.R., Opler, L.A., & Lindenmayer, J.P. (1989). The Positive and Negative Syndrome Scale (PANSS): Rationale and standardization. British Journal of Psychiatry, 155, 5967.
Kern, R.S., Green, M.F., Marshall, B.D., Jr., Wirshing, W.C., Wirshing, D., McGurk, S.R., Marder, S.R., & Mintz, J. (1999). Risperidone versus haloperidol on secondary memory: Can newer medications aid learning? Schizophrenia Bulletin, 25, 223232.
Lee, M.A., Jayathilake, K., & Meltzer, H.Y. (1999). A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia Research, 37, 111.
Liu, S.K., Chen, W.J., Chang, C.-J., & Lin, H.-N. (2000). Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: A trial of risperidone versus haloperidol. Neuropsychopharmacology, 22, 311319.
Lussier, I. & Stip, E. (2001). Memory and attention deficits in drug naive patients with schizophrenia. Schizophrenia Research, 48, 4555.
Meltzer, H.Y. & McGurk, S.R. (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin, 25, 233255.
Mori, K., Yamashita, H., Nagao, M., Horiguchi, J., & Yamawaki, S. (2002). Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry, 35, 611.
Nolin, P. (1999). Analyses psychométriques de l'adaptation Française du California Verbal Learning Test (CVLT) (Psychometric validation of French version of the CVLT). Revue Québécoise de Psychologie, 20, 3955.
Nuechterlein, K.H. & Dawson, M.E. (1984). Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophrenia Bulletin, 10, 160203.
Paulsen, J.S., Heaton, R.K., Sadek, J.R., Perry, W., Delis, D.C., Braff, D., Kuck, J., Zisook, S., & Jeste, D.V. (1995). The nature of learning and memory impairments in schizophrenia. Journal of the International Neuropsychological Society, 1, 8899.
Peuskens, J. (1995). Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. British Journal of Psychiatry, 166, 712726.
Pourcher, E., Thériault, M., & Lussier, J. (2000). Verbal retrieval in idiopathic Parkinson's disease: An “on-off” study. Movement Disorders, 15(Suppl. 3), 188.
Purdon, S.E., Jones, B.D.W., Stip, E., Labelle, A., Addington, D., David, S.R., Breier, A., & Tollefson, G.D. (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Archives of General Psychiatry, 57, 249258.
Rabinowitz, J. & Davidson, M. (2001). Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: A post hoc analysis. Schizophrenia Research, 50, 8993.
Rémillard, S., Pourcher, E., & Cohen, H. (2005). The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study. Schizophrenia Research, 80, 99106.
Shallice, T., Fletcher, P., Frith, C.D., Grasby, P., Frackowiak, R.S., & Doland, R.J. (1994). Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature, 14, 633635.
Stip, E. & Lussier, I. (1996). The effect of risperidone on cognition in patients with schizophrenia. Canadian Journal of Psychiatry, 41(Suppl. 2), 35S40S.
Strauss, M.E., Reynolds, K.S., Jayaram, G., & Tune, L.E. (1990). Effects of anticholinergic medication on memory in schizophrenia. Schizophrenia Research, 3, 127129.
Toichi, M., Findling, R.L., Kubota, Y., Calabrese, J.R., Wiznitzer, M., McNamara, N.K., & Yamamoto, K. (2004). Hemodynamic differences in the activation of the prefrontal cortex: Attention vs. higher cognitive processing. Neuropsychologia, 42, 698706.
Tulving, E., Kapur, S., Craik, F.I., Moscovitch, M., & Houle, S. (1994). Hemispheric encoding/retrieval asymmetry in episodic memory: Positron emission tomography findings. Proceedings of the National Academy of Sciences of the United States of America, 91, 20162020.
Vendrell, P., Junque, C., Pujol, J., Jurado, M.A., Molet, J., & Grafman, J. (1995). The role of prefrontal regions in the Stroop task. Neuropsychologia, 33, 341352.
Weiss, A.P., Zalesak, M., DeWitt, I., Goff, D., Kunkel, L., & Heckers, S. (2004). Impaired hippocampal function during the detection of novel words in schizophrenia. Biological Psychiatry, 55, 668675.
Yen, Y.-C., Lung, F.-W., & Chong, M.-Y. (2004). Adverse effects of risperidone and haloperidol treatment in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 28, 285290.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 7
Total number of PDF views: 80 *
Loading metrics...

Abstract views

Total abstract views: 130 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 15th December 2017. This data will be updated every 24 hours.